Peter Sullivan

Agency leaders portrayed the move as a major step toward keeping U.S. biomedical research competitive.

A rise in the uninsured rate will put more stress on the health system.

They called for stability and predictability at the agency at Axios' Future of Health summit.

Added insurance costs are being passed through to workers who are already reeling from inflation.

Democratic states are warning that a chaotic rollout could lead to even more people losing their coverage.

The new effort risks crossing the line into benefit cuts that could prompt political backlash in an election year.

Democrats argue Trump hasn't delivered meaningful results the way they did in 2022 through the Inflation Reduction Act.

Capping insulin costs at $35 per month in commercial insurance has been a goal for years.

Customers could be on the hook for thousands of more dollars in costs, worsening the health affordability crisis.

That doesn't mean controversies around vaccines and public health are over.